As we prepare for the festive season, it’s easy to let COVID boosters fall off our to-do lists. But COVID is still ...
The U.S. Food and Drug Administration (FDA) is considering adding the strongest safety warning available to COVID-19 vaccines ...
The first-in-human clinical phase I trial assessing the feasibility and safety of WDVAX, an immunostimulatory ...
NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...
COVID-19, RSV, and influenza immunizations show continued safety and substantial effectiveness against hospitalization across various populations.
Moderna on Monday said that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended the marketing authorization of mNexspike, a new Covid-19 vaccine. The committee's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results